|
ZDHHC17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.179400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.212900E-04 |
| Normal-vs-Stage2 |
7.192000E-02 |
| Normal-vs-Stage3 |
1.682020E-01 |
| Normal-vs-Stage4 |
8.068400E-01 |
| Stage1-vs-Stage2 |
9.898800E-01 |
| Stage1-vs-Stage3 |
1.100400E-01 |
| Stage1-vs-Stage4 |
5.135700E-03 |
| Stage2-vs-Stage3 |
3.507600E-01 |
| Stage2-vs-Stage4 |
1.082450E-01 |
| Stage3-vs-Stage4 |
3.053800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.097300E-03 |
| Normal-vs-AfricanAmerican |
2.757000E-01 |
| Normal-vs-Asian |
8.458200E-03 |
| Caucasian-vs-AfricanAmerican |
5.272400E-01 |
| Caucasian-vs-Asian |
2.435600E-01 |
| AfricanAmerican-vs-Asian |
1.281980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.716300E-02 |
| Normal-vs-Female |
2.986000E-04 |
| Male-vs-Female |
7.822600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.293000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.104600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.353600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.287400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.719420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.194400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.680600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.975210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.631200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.612400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.31960000000231E-05 |
| Normal-vs-Grade 2 |
3.76050000000516E-05 |
| Normal-vs-Grade 3 |
1.845380E-01 |
| Normal-vs-Grade 4 |
1.852190E-01 |
| Grade 1-vs-Grade 2 |
2.238600E-01 |
| Grade 1-vs-Grade 3 |
1.043570E-03 |
| Grade 1-vs-Grade 4 |
3.76560000000525E-05 |
| Grade 2-vs-Grade 3 |
4.970000E-04 |
| Grade 2-vs-Grade 4 |
2.75819999950855E-07 |
| Grade 3-vs-Grade 4 |
7.804800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.48049999984623E-07 |
| Normal-vs-ccB subtype |
8.550800E-01 |
| ccA subtype-vs-ccB subtype |
6.85130000510625E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.060400E-03 |
| Normal-vs-N1 |
4.456600E-01 |
| N0-vs-N1 |
9.418000E-02 |
|
|
